Skip to content

Robust ML Approach for Screening MET Drug Candidates in Combination with Immune Checkpoint Inhibitors

Present study highlights the significance of dataset size in ICI microbiota models and presents a methodology to enhance the performances of a multi-cohort-based ML approach. Conditioned to the performances we obtained, the healthy-pooled-donors-derived DS harbor a considerable ratio (91%) of ‘ICI Responder-like’, significantly higher than the mono-donor stools (73%) suggesting that pooled ecosystems from healthy donors could better convert ICI-non responders into responders.

Emmanuel Prestat, Elsa Schalck, Antoine Bonnefoy, Antoine Sabourin, Cyrielle Gasc, Carole Schwintner and Nathalie Corvaia, Robust machine learning approach for screening microbiome ecosystem therapies (MET) drug candidates in combination with immune checkpoint inhibitorsJournal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.1304

 Click here to access the paper.
 

Releated Posts

Insights from GTC Paris 2025

Among the NVIDIA GTC Paris crowd was our CTO Sabri Skhiri, and from quantum computing breakthroughs to the full-stack AI advancements powering industrial digital twins and robotics, there is a lot to share! Explore with Sabri GTC 2025 trends, keynotes, and what it means for businesses looking to innovate.
Read More

Development & Evaluation of Automated Tumour Monitoring by Image Registration Based on 3D (PET/CT) Images

Tumor tracking in PET/CT is essential for monitoring cancer progression and guiding treatment strategies. Traditionally, nuclear physicians manually track tumors, focusing on the five largest ones (PERCIST criteria), which is both time-consuming and imprecise. Automated tumor tracking can allow matching of the numerous metastatic lesions across scans, enhancing tumor change monitoring.
Read More